Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study

Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study

Introduction: Phosphodiesterase type 5 inhibitors (PDE5i) are first-line therapy for most men with erectile dysfunction (ED). If ineffective, vacuum erection devices, intracavernous injections, and penile prosthesis implantation are suitable as second- or third-line therapies. However, very few pati...

Full description

Bibliographic Details
Main Authors: Masato Shirai, MD, PhD, Ippei Hiramatsu, MD, Yusuke Aoki, MD, Hirofumi Shimoyama, MD, PhD, Taiki Mizuno, MD, PhD, Taiji Nozaki, MD, PhD, Shinichiro Fukuhara, MD, PhD, Atsushi Iwasa, MD, PhD, Shinji Kageyama, MD, PhD, Akira Tsujimura, MD, PhD
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Sexual Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2050116118300618

Internet

http://www.sciencedirect.com/science/article/pii/S2050116118300618

Similar Items